The first circular for the 16th RSC-SCI Medicinal Chemistry Symposium, 11-14 September 2011, Churchill College, Cambridge, UK is now available here.

Scientifc Program includes:-

• Strategies to success - H-PGDS inhibitors for the treatment of inflamatory disorders, Sukanthini Thurauratnam, Sanofi -Aventis

• Discovery on next generation glucokinase activators, Mike Waring, AstraZeneca

• Inhalation by design, Paul Glosson, Pfizer

• Bromodomains a new class of epigenetic targets for small molecule drug discovery, Jason Witherington, GSK

• GPCR Structure based drug design using stabilised receptors(StaRs), Miles Congreve, Heptares

• GS-9350: a novel pharmacoenhancer, Lianhong Xu, Gilead Sciences